The collapse of stalled replication forks is a major driver of genomic instability. Several committed mechanisms exist to resolve replication stress. These pathways are particularly pertinent at telomeres. Cancer cells that use Alternative Lengthening of Telomeres (ALT) display heightened levels of telomere-specific replication stress, and co-opt stalled replication forks as substrates for break-induced telomere synthesis. FANCM is a DNA translocase that can form independent functional interactions with the BLM-TOP3A-RMI (BTR) complex and the Fanconi anemia (FA) core complex. Here, we demonstrate that FANCM depletion provokes ALT activity, evident by increased break-induced telomere synthesis, and the induction of ALT biomarkers. FANCM-medi...
In an effort to achieve replicative immortality, human cancer cells must avoid the constant telomere...
FANCM is the most highly conserved protein within the Fanconi anaemia (FA) tumour suppressor pathway...
Fifteen percent of tumors utilize recombination-based alternative lengthening of telomeres (ALT) to ...
Alternative Lengthening of Telomeres (ALT) is a telomere maintenance mechanism employed by a subset ...
Telomerase negative immortal cancer cells elongate telomeres through the Alternative Lengthening of ...
In humans, telomeres consist of ′TTAGGG′ repeats, which form a nucleoprotein complex that caps the e...
Telomeres are repetitive DNA sequences located at the ends of linear eukaryotic chromosomes. Maligna...
Most immortal human cells maintain their telomeres by up-regulating the enzyme telomerase. Approxima...
Fanconi anaemia (FA)-related proteins function in interstrand crosslink (ICL) repair pathways and mu...
Break-induced replication is a specific type of DNA repair that has a co-opted role in telomere exte...
Approximately 15% of human cancers utilize a recombination-based mechanism termed Alternative Length...
Both Fanconi anemia (FA) and telomere dysfunction are associated with chromosome instability and an ...
Both Fanconi anemia (FA) and telomere dysfunction are associated with chromosome instability and an ...
Both Fanconi anemia (FA) and telomere dysfunction are associated with chromosome instability and an ...
Fanconi anaemia (FA) is an inherited disorder characterized by bone marrow failure, cancer predispos...
In an effort to achieve replicative immortality, human cancer cells must avoid the constant telomere...
FANCM is the most highly conserved protein within the Fanconi anaemia (FA) tumour suppressor pathway...
Fifteen percent of tumors utilize recombination-based alternative lengthening of telomeres (ALT) to ...
Alternative Lengthening of Telomeres (ALT) is a telomere maintenance mechanism employed by a subset ...
Telomerase negative immortal cancer cells elongate telomeres through the Alternative Lengthening of ...
In humans, telomeres consist of ′TTAGGG′ repeats, which form a nucleoprotein complex that caps the e...
Telomeres are repetitive DNA sequences located at the ends of linear eukaryotic chromosomes. Maligna...
Most immortal human cells maintain their telomeres by up-regulating the enzyme telomerase. Approxima...
Fanconi anaemia (FA)-related proteins function in interstrand crosslink (ICL) repair pathways and mu...
Break-induced replication is a specific type of DNA repair that has a co-opted role in telomere exte...
Approximately 15% of human cancers utilize a recombination-based mechanism termed Alternative Length...
Both Fanconi anemia (FA) and telomere dysfunction are associated with chromosome instability and an ...
Both Fanconi anemia (FA) and telomere dysfunction are associated with chromosome instability and an ...
Both Fanconi anemia (FA) and telomere dysfunction are associated with chromosome instability and an ...
Fanconi anaemia (FA) is an inherited disorder characterized by bone marrow failure, cancer predispos...
In an effort to achieve replicative immortality, human cancer cells must avoid the constant telomere...
FANCM is the most highly conserved protein within the Fanconi anaemia (FA) tumour suppressor pathway...
Fifteen percent of tumors utilize recombination-based alternative lengthening of telomeres (ALT) to ...